Showing 2341-2350 of 9108 results for "".
DWTV Extra: New Tapinarof Data for AD
https://practicaldermatology.com/videos/dermwire-tv/dwtv-extra-new-tapinarof-data-for-ad/33940/Linda Stein Gold, MD, discusses the results from the Phase 3 ADORING 3 open-label, long-term extension study evaluating tapinarof cream, 1% once daily in children as young as 2 and adults with atopic dermatitis, presented at the 2025 American Academy of Dermatology (AAD) Annual Meeting in OrlandoStep Therapy Reform Advocates Seek to Spread Awareness of Proposed Law
https://practicaldermatology.com/issues/practicaldermatology-com-march-2025/step-therapy-reform-advocates-seek-to-spread-awareness-of-proposed-law/33160/The Safe Step Act would stop insurance companies under certain circumstances from requiring alternative medications before covering biologics.New Hope for Patients with Onychomycosis
https://practicaldermatology.com/issues/practicaldermatology-com-march-2025/new-hope-for-patients-with-onychomycosis/33161/Onychomycosis, a non-self-healing fungal infection of the toenails or fingernails, is a common infection accounting for 20% of all nail diseases in adults, affecting 5% of the worldwide population.What's New in Atopic Dermatitis?
https://practicaldermatology.com/programs/practical-dermatology/whats-new-in-atopic-dermatitis/33014/Emma Guttman, MD, PhD, professor and chair of dermatology at Mount Sinai, talks about the latest developments in treatments and therapies for atopic dermatitis.In-Depth From the Science of Skincare Summit
https://practicaldermatology.com/issues/january-february-2025/in-depth-from-the-science-of-skincare-summit/32979/The 2024 Science of Skincare Summit this past November again positioned itself as a pivotal event in the dermatology field, offering groundbreaking insights into the intersection of innovation, consumer trends, and evidence-based skincare. Take a closer look at some of the research.Dermwire TV Extra: The Global Access to Skin Health Observatory
https://practicaldermatology.com/videos/dermwire-tv/global-access-skin-health-observatory/29873/Esther Freeman, MD, PhD, Director of Global Health Dermatology at Massachusetts General Hospital and Harvard Medical School, and Vice Chair of the International Foundation of Dermatology with the International League of Dermatological Societies (ILDS), talks with Practical Dermatology about her workScience of Skincare Summit 2024: Social Media as Education Tool
https://practicaldermatology.com/conferences/science-skincare-summit-2024/science-of-skincare-summit-2024-social-media-as-education-tool/29448/Jennifer Liu, MD, a dermatologist and social media influencer (dermfluencer) talks with Practical Dermatology about using social media at a tool to educate various audiences with correct information about both products and conditions such as atopic dermatitis and psoriasis. This video was recorded aWhat are Dermatologists’ Obstacles to Buy and Bill?
https://practicaldermatology.com/conferences/maui-derm-2024/what-are-dermatologists-obstacles-to-buy-and-bill/20241/Challenges with fee schedules have prompted many dermatologists to consider the buy and bill model. In a conversation between Practical Dermatology’s Chief Medical Editor Neal Bhatia, MD and Mark Kaufmann, MD, associate clinical professor at Mount Sinai, the doctors discuss some of the opportunitiesTo Sell or Not to Sell to Private Equity?
https://practicaldermatology.com/conferences/scale-2023/to-sell-or-not-to-sell-to-private-equity/20195/Joel L. Cohen, MD, and George Hruza MD, discuss the pros and cons of selling to private equity. Pros include back-office support and better pricing on technology and supplies, while cons can include giving up autonomy.Weighing the Safety of Sunscreens
https://practicaldermatology.com/topics/skin-cancer-photoprotection/the-safety-of-sunscreens/20172/Adam Friedman, MD, provides compelling reasons to question the recent studies on sunscreen safety.